Toggle navigation
Home
Search
Services
Blog
Contact
About
Molecular Characterization of Opiate Binding Sites
Bero, Lisa A.
University of California San Francisco, San Francisco, CA, United States
Search 11 grants from Lisa Bero
Search grants from University of California San Francisco
Share this grant:
:
:
Abstract
Funding
Institution
Publications
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Novel use of video analysis to assay weight and body features
National ON-Line Resource Center for Violence Against Women
Tissue Specific Borrelia Gene Expession
Chronic Hepatitis C W/ Intron & Ribavirin Combination Therapy
Effects of Adenosine in Arrhythmias From Triggered Automaticity
Recently added grants:
Low Molecular Weight Protein Nephrotoxicity
Sex Effects on the Neurobiology of Eating Behaviors in Veterans with Overweight/Obesity
A pragmatic randomized comparator trial of eszopiclone and brief behavioral therapy for insomnia in CPAP non adherent Veterans with PTSD and complex insomnia
Nutrition, Inflammation and Insulin Resistance in End-Stage Renal Disease
A pharmaco-imaging approach to predicting social functioning and clinical responses to oxytocin administration in schizophrenia
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32DA005327-01
Application #
3035173
Study Section
(SRCD)
Project Start
1988-02-01
Project End
Budget Start
1987-11-01
Budget End
1988-10-31
Support Year
1
Fiscal Year
1987
Total Cost
Indirect Cost
Institution
Name
University of California San Francisco
Department
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Publications
Bero, L A; Roy, S; Lee, N M
(1988)
Identification of endogenous opioid receptor components in rat brain using a monoclonal antibody.
Mol Pharmacol 34:614-20
Comments
Be the first to comment on this grant